Responsible Opioid Use for Hip and Knee Arthroplasty (Opioidhalt II) Study

Not Applicable

• Conditions: opioid use; total knee arthroplasty; Public Health - Health service research; total hip arthroplasty; Anaesthesiology - Pain management

• Registration Number: ACTRN12623000685617
• Lead Sponsor: The Commonwealth of Australia represented by the Department of Health and Aged Care (Funding Agreement managed by The Department of Industry, Science and Resources)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-06-26
• Last Update Posted: 22 April 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 314

Inclusion Criteria

Randomized Study:
Aged 18 years or older, undergoing elective THA or TKA for osteoarthritis, speaks and reads English, uses prescription opioid analgesics daily, and has access to the internet or telephone.
Criteria for GP review: Psychological distress and suicidality will be screened using the 6-item Kessler Psychological Distress Scale (K6) and the 3-item Patient Safety Screener (PSS). Patients with: (i) a K6 score of 19 or greater AND PSS criteria 1 (feeling down, depressed, or hopeless over past two weeks); OR (ii) PSS criteria 2 (thoughts of killing yourself over past two weeks); OR (iii) PSS criteria 3 (ever attempted to kill yourself) AND report suicidality in the past 6 months will be referred to their GP to confirm whether participation in the trial is appropriate.

Exclusion Criteria

Patients undergoing planned repeat surgeries (same procedure within 6 months), using opioids for cancer, palliative care, or substance use disorder, previously or already undergoing an opioid tapering program or active medication review, and major cognitive impairment.

Study & Design

• Study Type: Interventional
• Study Design: Not specified